KalVista Corp (KALV) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

KalVista Corp - KALV emitenti grafik logotipi

KalVista Pharmaceuticals (KALV) dori vositalarini ishlab chiqish jarayonida zararli emissiyalarni minimallashtirish va suvni tejash orqali "yashil kimyo" tamoyillariga amal qiladi. Biznes noyob patologiyalarni davolash uchun molekulalarni kashf etishni tezlashtirish maqsadida AI va avtomatlashtirishdan foydalanadi. Aktivning 0.00 miqdoridagi bozor qiymati dinamikasi brend pozitsiyasining barqarorligini tasdiqlaydi, bu esa eksklyuziv FDA patentlari va yangi ishtirokchilar uchun yuqori kirish to'siqlarini yaratuvchi ulkan R&D xarajatlari bilan himoyalangan.

KalVista Pharma (KALV): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 21.06.2026gacha

KalVista Pharmaceuticals (KALV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi KalVista Pharma|KALV - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati KalVista Pharmaceuticals, Inc.|KALV - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati KalVista Pharmaceuticals|KALV - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati kalvista.com|KALV - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati kalvista.com|KALV - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati KalVista Pharmaceuticals, Inc.|KALV - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi KalVista Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi kalvista.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
KALV - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:KalVista Pharma - KALV
KalVista Pharmaceuticals brend mahsuloti

Ushbu ko'rsatkich balans hisoboti tuzilmasining barqarorligini baholash uchun uzoq muddatli qarzlar va umumiy kapitalni taqqoslagan holda moliyaviy leveraj darajasini o'lchaydi. Bir yildan ortiq muddatli majburiyatlarning kapitalga nisbatini tahlil qilish orqali investor KalVista Pharmaceuticals (KALV) kompaniyasining to'lov qobiliyati riskini aniqlaydi, uning klinik sinovlar va ishlab chiqarishni autsorsing qilish modeli qarz yuklamasini xizmat ko'rsatishda tashqi pudratchilarga bo'lgan bog'liqlikni oshiradi.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA - Uzoq muddatli qarzning kapitalga nisbati|RIGL: Uzoq muddatli qarzning kapitalga nisbati|anaptysbio.com (ANAB) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT (RAPT Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati JBIO (aerovatetx.com)|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati kyvernatx.com (KYTX)|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cabaletta Bio Inc. CABA|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX: Uzoq muddatli kreditlarning kapitalga nisbati|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati eledon.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited ZURA|ATYR (aTyr Pharmaceuticals) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|STTK: Uzoq muddatli qarzning kapitalga nisbati|Equillium (EQ) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|IMUX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|Uzoq muddatli qarzning o'z kapitaliga nisbati inflarx.de IFRX|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Adicet Bio Inc. ACET|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INmune Bio Corporation (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati kezarlifesciences.com (KZR)|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|Uzoq muddatli qarzning kapitalga nisbati Akari Therapeutics PLC|Uzoq muddatli qarzning o'z kapitaliga nisbati ENLV (Enlivex Therapeutics)|Uzoq muddatli kreditlarning kapitalga nisbati QTTB|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|iBio - Uzoq muddatli qarzning kapitalga nisbati|Carisma Therapeutics (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Bolt Biotherapeutics, Inc. (BOLT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzdorlikning kapitalga nisbati aditxt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|SCNI (Scinai Immunotherapeutics Ltd) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI|Uzoq muddatli qarzning o'z kapitaliga nisbati AFMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|HOOK: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati